Fidelis Animal Health offers exceptional expertise in the acquisition, development, and marketing of unique pharmaceutical formulations that meet specialized veterinary needs.
Ethiqa XR is the only pharmaceutical grade extended-release buprenorphine specifically developed for the control of post-procedural pain in captive rodents, ferrets, laboratory animals, and non-human primates. Ethiqa XR provides up to 72 hours of pain relief with just one injection.
Fidelis Pharmaceuticals is a privately held U.S.-based company serving the world from the Northeast pharmaceutical corridor:
Company headquarters is located in New Jersey.
Ethiqa XR is manufactured in Pennsylvania.
Supply chain sources and manufacturing sites and operations are in full compliance with current Good Manufacturing Practices (cGMPs) regulated by the FDA.
Dedicated to providing products that are indexed by the FDA.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 675 Highway One,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://fidelisah.com/
- Keywords
- Darra.
- HQ
- North Brunswick, NJ
Fidelis Animal Health Questions
Fidelis Animal Health's website is http://fidelisah.com/
Fidelis Animal Health's LinkedIn profile is https://www.linkedin.com/company/fidelisah
Fidelis Animal Health has
7 employees.
View email and phone details for 7
employees at Fidelis Animal Health.
Fidelis Animal Health's industry is
Pharmaceutical Manufacturing
Fidelis Animal Health's top competitors are
Apiam Animal Health Limited,
Pharmgate Animal Health,
Kaléo,
Zebravet Australia Pty Ltd,
Mavlab Animal Health Pty Ltd,
Alleva Animal Health,
Endovac Animal Health,
Jaguar Animal Health,
Canopy Animal Health,
Sonnet Biotherapeutics.
Fidelis Animal Health's categories are Pharmaceutical Manufacturing
Fidelis Animal Health's founding year is 2016
